Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/11467
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | SLAETS, Leen | - |
dc.contributor.author | HENDRIKS, Jerome | - |
dc.contributor.author | STINISSEN, Piet | - |
dc.contributor.author | Kilpatrick, Trevor J. | - |
dc.contributor.author | HELLINGS, Niels | - |
dc.date.accessioned | 2011-01-09T08:29:09Z | - |
dc.date.available | NO_RESTRICTION | - |
dc.date.available | 2011-01-09T08:29:09Z | - |
dc.date.issued | 2010 | - |
dc.identifier.citation | TRENDS IN MOLECULAR MEDICINE, 16 (11). p. 493-500 | - |
dc.identifier.issn | 1471-4914 | - |
dc.identifier.uri | http://hdl.handle.net/1942/11467 | - |
dc.description.abstract | Therapies for multiple sclerosis (MS) reduce the relapse rate but are unable to stop neurological decline. Here, we evaluate the potential of leukemia inhibitory factor (LIF) as a novel therapeutic in diseases with a neurodegenerative and inflammatory component, such as MS. LIF, which can be a proinflammatory cytokine, can also modulate the immune response in a beneficial way. Recent evidence demonstrates a crucial role of LIF in neuroprotection and axonal regeneration as well as the prevention of demyelination. Finally, LIF is an important survival factor for stem cells and neuronal precursors. Therefore, we propose that LIF is a potential therapeutic candidate for MS. | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCI LTD | - |
dc.subject.other | biochemistry & molecular biology; cell biology; medicine, research & experimental | - |
dc.title | Therapeutic potential of LIF in multiple sclerosis | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 500 | - |
dc.identifier.issue | 11 | - |
dc.identifier.spage | 493 | - |
dc.identifier.volume | 16 | - |
local.format.pages | 8 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | [Slaets, Helena; Hendriks, Jerome J. A.; Stinissen, Piet; Hellings, Niels] Hasselt Univ, Biomed Res Inst, Diepenbeek, Belgium. [Slaets, Helena; Hendriks, Jerome J. A.; Stinissen, Piet; Hellings, Niels] Transnat Univ Limburg, Sch Life Sci, Diepenbeek, Belgium. [Kilpatrick, Trevor J.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia. [Kilpatrick, Trevor J.] Univ Melbourne, Howard Florey Inst, Melbourne, Vic 3010, Australia. 000284729500001 | - |
local.type.refereed | Refereed | - |
local.type.specified | Review | - |
dc.bibliographicCitation.oldjcat | A1 | - |
dc.identifier.doi | 10.1016/j.molmed.2010.08.007 | - |
dc.identifier.isi | 000284729500001 | - |
item.validation | ecoom 2011 | - |
item.fulltext | With Fulltext | - |
item.fullcitation | SLAETS, Leen; HENDRIKS, Jerome; STINISSEN, Piet; Kilpatrick, Trevor J. & HELLINGS, Niels (2010) Therapeutic potential of LIF in multiple sclerosis. In: TRENDS IN MOLECULAR MEDICINE, 16 (11). p. 493-500. | - |
item.accessRights | Restricted Access | - |
item.contributor | SLAETS, Leen | - |
item.contributor | HENDRIKS, Jerome | - |
item.contributor | STINISSEN, Piet | - |
item.contributor | Kilpatrick, Trevor J. | - |
item.contributor | HELLINGS, Niels | - |
crisitem.journal.issn | 1471-4914 | - |
crisitem.journal.eissn | 1471-499X | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
slaets.pdf Restricted Access | Published version | 204.42 kB | Adobe PDF | View/Open Request a copy |
SCOPUSTM
Citations
28
checked on Sep 2, 2020
WEB OF SCIENCETM
Citations
33
checked on Oct 12, 2024
Page view(s)
140
checked on Aug 31, 2022
Download(s)
160
checked on Aug 31, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.